Publicação: Study of mastoparan analog peptides against Candida albicans and safety in zebrafish embryos (Danio rerio)
dc.contributor.author | Galeane, Mariana C. [UNESP] | |
dc.contributor.author | Gomes, Paulo C. [UNESP] | |
dc.contributor.author | L Singulani, Junya de [UNESP] | |
dc.contributor.author | de Souza, Bibiana M. [UNESP] | |
dc.contributor.author | Palma, Mario S. [UNESP] | |
dc.contributor.author | Mendes-Giannini, Maria Js [UNESP] | |
dc.contributor.author | Almeida, Ana Mf [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2019-10-06T16:47:15Z | |
dc.date.available | 2019-10-06T16:47:15Z | |
dc.date.issued | 2019-09-01 | |
dc.description.abstract | Aim: In this work, mastoparan analog peptides from wasp venom were tested against Candida albicans and safety assays were performed using cell culture and model zebrafish. Materials & methods: Minimal inhibitory concentration was determined and toxicity was performed using human skin keratinocyte and embryo zebrafish. Also, permeation of peptides through embryo chorion was performed. Results: The peptides demonstrated anti-C. albicans activity, with low cytotoxicity and nonteratogenicity in Danio rerio. The compounds had different permeation through chorion, suggesting that this occurs due to modifications in their amino acid sequence. Conclusion: The results showed that the studied peptides can be used as structural study models for novel potential antifungal agents. | en |
dc.description.affiliation | Department of Clinical Analysis School of Pharmaceutical Sciences São Paulo State University-UNESP | |
dc.description.affiliation | Department of Biology Institute of Biosciences São Paulo State University-UNESP, CEIS / LSBZ | |
dc.description.affiliationUnesp | Department of Clinical Analysis School of Pharmaceutical Sciences São Paulo State University-UNESP | |
dc.description.affiliationUnesp | Department of Biology Institute of Biosciences São Paulo State University-UNESP, CEIS / LSBZ | |
dc.format.extent | 1087-1097 | |
dc.identifier | http://dx.doi.org/10.2217/fmb-2019-0060 | |
dc.identifier.citation | Future microbiology, v. 14, p. 1087-1097. | |
dc.identifier.doi | 10.2217/fmb-2019-0060 | |
dc.identifier.issn | 1746-0921 | |
dc.identifier.scopus | 2-s2.0-85072121350 | |
dc.identifier.uri | http://hdl.handle.net/11449/189644 | |
dc.language.iso | eng | |
dc.relation.ispartof | Future microbiology | |
dc.rights.accessRights | Acesso restrito | pt |
dc.source | Scopus | |
dc.subject | antimicrobial peptides | |
dc.subject | candidiasis | |
dc.subject | chorion | |
dc.subject | mass spectrometry | |
dc.subject | mastoparans | |
dc.subject | toxicity | |
dc.title | Study of mastoparan analog peptides against Candida albicans and safety in zebrafish embryos (Danio rerio) | en |
dc.type | Artigo | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | a83d26d6-5383-42e4-bb3c-2678a6ddc144 | |
relation.isDepartmentOfPublication.latestForDiscovery | a83d26d6-5383-42e4-bb3c-2678a6ddc144 | |
unesp.author.lattes | 3716273524139678[7] | |
unesp.author.orcid | 0000-0002-2115-8988[7] | |
unesp.department | Análises Clínicas - FCF | pt |